Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Alibaba Group (BABA) vs Revvity Inc (RVTY) Price & Performance

Alibaba GroupTrade
Revvity IncTrade

Price performance (Past 24H)

Key statistics

Alibaba Group vs Revvity Inc — how do they compare? Alibaba Group trades at $116.79 (market cap $270.95B), while Revvity Inc trades at $110.91 (market cap $12.41B). The key difference: Alibaba Group is far larger — about 21.8× Revvity Inc's market cap, and Alibaba Group pays the higher dividend (0.93%). Which is the better fit depends on your goals.

BABARVTY
Market Cap
$270.95B$12.41B
Volume
18,069,938
Sector
Consumer CyclicalTechnology
52-Week High
$189.34$117.75
52-Week Low
$94.83$82.26
Enterprise Value
$265.77B$14.90B
Dividend Yield
0.93%0.25%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Alibaba Group

Alibaba (BABA) trades at $112.35, up 0.02% on the day, with a bullish technical signal and strong analyst consensus. Recent earnings misses contrast with robust fundamentals: revenue grew to $996.35B in 2025, net income margin expanded to 13.05%, and valuation ratios like P/E of 17.36 appear reasonable. The stock faces headwinds from securities investigations but benefits from AI-driven optimism in cloud growth.

Outlook remains positive given Wall Street's $195 price target and 86% buy ratings, though risks include legal overhangs and earnings volatility. AI and cloud initiatives offer growth catalysts, but investors should monitor regulatory developments and quarterly execution against expectations.

Revvity Inc

RVTY trades at $111.11, down 1.05% today, with a bullish technical signal from moving averages. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $1.06 exceeding expectations. Recent developments include AI integration with Anthropic's Claude and FDA clearance for a testosterone assay, signaling innovation in diagnostics and life sciences.

The outlook remains positive with strong analyst support (51.72% buy ratings) and a consensus price target of $111.43. Key risks include margin pressure from China divestment plans and weak academic demand. Revenue stability around $2.9B supports valuation, though high P/E of 53.47 requires sustained growth to justify.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Alibaba Group

Alibaba Group Holding Limited operates as a holding company. The Company provides internet infrastructure, electronic commerce, online financial, and internet content services through its subsidiaries. Alibaba Group Holding offers its products and services worldwide.

Read more on BABA

About Revvity Inc

Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.

Read more on RVTY